SCHEMBL10145862

SCHEMBL10145862

Cc1ccccc1-c1ccc2c(c1)n(C)c(=O)n2C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.51
MTOR P42345 3/20 0.51
PRKDC P78527 2/20 0.51
HSD11B1 P28845 2/20 0.48
PRKCG P05129 1/20 0.43
PRKCB P05771 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCH P24723 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCD Q05655 1/20 0.43
GPR119 Q8TDV5 5/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OGFRL1 Q5TC84 1/20 0.40
CTSD P07339 1/20 0.40
CTSE P14091 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14992429 0.89 HSD11B1 (0.53) PIK3CAMTORPRKDCHSD11B1L3MBTL1
SCHEMBL20496328 0.86 HSD11B1 (0.51) PIK3CAMTORPRKDCHSD11B1L3MBTL1
SCHEMBL6160925 0.84 HSD11B1 (0.56) PIK3CAMTORPRKDCHSD11B1PRKCG
SCHEMBL17803254 0.81 HSD11B1 (0.61) PIK3CAMTORPRKDCHSD11B1MEN1
SCHEMBL29171247 0.81 PIK3CA (0.52) PIK3CAMTORPRKDCHSD11B1PRKCG
SCHEMBL10146347 0.81 HSD11B1 (0.46) PIK3CAMTORPRKDCHSD11B1
SCHEMBL10145870 0.80 HTR7 (0.43) PIK3CAMTORPRKDCHSD11B1
SCHEMBL14992973 0.77 PIK3CA (0.51) PIK3CAMTORPRKDCHSD11B1
SCHEMBL14992428 0.76 HSD11B1 (0.41) PIK3CAMTORPRKDCHSD11B1
SCHEMBL4440180 0.76 GPR119 (0.52) PIK3CAMTORPRKDCHSD11B1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603079-B1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME (US) 2018-09-19 EP disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
WO-2012021382-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME CORP. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 GRM2, GRIA2, GRM1 PIK3CA 1854/4885MTOR 1896/4885PRKDC 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.